Christine Jenkins's Publications

About Christine Jenkins's Publications

Program Head, Respiratory
  • Professor of Respiratory Medicine, Faculty of Medicine, UNSW Sydney
  • Clinical Professor, Concord Clinical School, University of Sydney
  • AM,
  • MD,
  • FRACP,
  • FThor ,
  • Soc ,
  • FAAHMS

  • Does continuous use of inhaled corticosteroids improve outcomes in mild asthma? A double-blind randomised controlled trial

    Primary Care Respiratory Journal Date published:

  • COPD management. Part I. Strategies for managing the burden of established COPD

    International Journal of Tuberculosis and Lung Disease Date published:

  • Engaging Employees in Community Investment at Pfizer

    Corporate Reputation Review Date published:

  • ‘You have to learn to live with it’: a qualitative and quantitative study of older people with asthma

    The Clinical Respiratory Journal Date published:

  • Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

    American Journal of Respiratory and Critical Care Medicine Date published:

  • Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease

    New England Journal of Medicine Date published:

  • Asthma management and outcomes in Australia: A nation-wide telephone interview survey*

    Respirology Date published:

  • Anxiety, panic and adult asthma: A cognitive-behavioral perspective

    Respiratory Medicine Date published:

  • Patient preferences for managing asthma: results from a discrete choice experiment

    Health Economics Date published:

  • The needs of older people with asthma

    Australian Family Physician Date published:

  • Using discrete choice experiments to investigate subject preferences for preventive asthma medication

    Respirology Date published:

  • THE TOWARDS A REVOLUTION IN COPD HEALTH (TORCH) STUDY: FLUTICASONE PROPIONATE/SALMETEROL IS WELL TOLERATED IN PATIENTS WITH COPD OVER 3 YEARS

    CHEST Date published:

  • THE TOWARDS A REVOLUTION IN COPD HEALTH (TORCH) STUDY: FLUTICASONE PROPIONATE/SALMETEROL IMPROVES AND SUSTAINS HEALTH STATUS IN COPD OVER 3 YEARS

    CHEST Date published:

  • THE TOWARDS A REVOLUTION IN COPD HEALTH (TORCH) STUDY: FLUTICASONE PROPIONATE/SALMETEROL REDUCES THE RATE OF EXACERBATIONS OVER 3 YEARS

    CHEST Date published:

  • THE TOWARDS A REVOLUTION IN COPD HEALTH (TORCH) STUDY: FLUTICASONE PROPIONATE/SALMETEROL IMPROVES SURVIVAL IN COPD OVER THREE YEARS

    CHEST Date published:

  • Features of glossopharyngeal breathing in breath-hold divers

    Journal of Applied Physiology Date published: